FDA Approval Makes a Zevra Drug the First Therapy for Rare and Fatal Metabolic Disease
A Zevra Therapeutics drug is now the first FDA-approved therapy for an ultra-rare, inherited metabolic disorder whose effects on the central nervous system can become fatal by the time a patient is a teenager. The drug, acrimoclomol, treats Niemann-Pick …